Advertisement
Loading...

Rebus Holdings, Inc.

RBSHPNK
Healthcare
Biotechnology
$0.00
$0.00(9900.000%)
U.S. Market opens in NaNh NaNm

Rebus Holdings, Inc. Fundamental Analysis

Rebus Holdings, Inc. (RBSH) shows moderate financial fundamentals with a PE ratio of -0.00, profit margin of 0.00%, and ROE of 19.88%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position157.14%
PEG Ratio0.00

Areas of Concern

Operating Margin0.00%
Current Ratio0.00
We analyze RBSH's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 50.6/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
50.6/100

We analyze RBSH's fundamental strength across five key dimensions:

Efficiency Score

Weak

RBSH struggles to generate sufficient returns from assets.

ROA > 10%
-204.00%

Valuation Score

Excellent

RBSH trades at attractive valuation levels.

PE < 25
-0.00
PEG Ratio < 2
0.00

Growth Score

Moderate

RBSH shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

RBSH shows balanced financial health with some risks.

Debt/Equity < 1
-0.06
Current Ratio > 1
0.00

Profitability Score

Weak

RBSH struggles to sustain strong margins.

ROE > 15%
19.88%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is RBSH Expensive or Cheap?

P/E Ratio

RBSH trades at -0.00 times earnings. This suggests potential undervaluation.

-0.00

PEG Ratio

When adjusting for growth, RBSH's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values Rebus Holdings, Inc. at -0.00 times its book value. This may indicate undervaluation.

-0.00

EV/EBITDA

Enterprise value stands at 0.45 times EBITDA. This is generally considered low.

0.45

How Well Does RBSH Make Money?

Net Profit Margin

For every $100 in sales, Rebus Holdings, Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $19.88 in profit for every $100 of shareholder equity.

19.88%

ROA

Rebus Holdings, Inc. generates $-204.00 in profit for every $100 in assets, demonstrating efficient asset deployment.

-204.00%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

RBSH converts -219.73% of its market value into free cash.

-219.73%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.00

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.06

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.001

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.20

vs 25 benchmark

ROA

Return on assets percentage

-204.00

vs 25 benchmark

ROCE

Return on capital employed

0.13

vs 25 benchmark

How RBSH Stacks Against Its Sector Peers

MetricRBSH ValueSector AveragePerformance
P/E Ratio-0.0029.24 Better (Cheaper)
ROE19.88%713.00% Weak
Net Margin0.00%-42604.00% (disorted) Weak
Debt/Equity-0.060.46 Strong (Low Leverage)
Current Ratio0.004.36 Weak Liquidity
ROA-20400.00%-16668.00% (disorted) Weak

RBSH outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Rebus Holdings, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ